SCHEMBL14999983

SCHEMBL14999983

CCN(CC)C(=O)C(Cc1ccccc1)C(=O)NS(=O)(=O)c1ccc(CC(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.46
LARS1 Q9P2J5 2/20 0.45
ALDH1A1 P00352 3/20 0.44
OPRK1 P41145 1/20 0.43
LIMK1 P53667 1/20 0.43
LIMK2 P53671 1/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.42
TARS1 P26639 1/20 0.41
HDAC1 Q13547 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097100 0.87 GAA (0.53) GAALARS1ALDH1A1LMNAHPGD
SCHEMBL3085973 0.85 LARS1 (0.53) LARS1ALDH1A1LMNAHPGDKDM4E
SCHEMBL15000139 0.85 ALDH1A1 (0.46) LARS1ALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL14999974 0.84 LARS1 (0.49) LARS1ALDH1A1LMNAKDM4EKMT2A
SCHEMBL14999959 0.83 TARS1 (0.52) ALDH1A1LMNAMEN1KMT2ATARS1
SCHEMBL3088272 0.83 MMP8 (0.60) GAALARS1ALDH1A1OPRK1LMNA
SCHEMBL15000273 0.82 BCL2 (0.48) LMNASMN1; SMN2MEN1KMT2AMMP2
SCHEMBL15000281 0.82 F2 (0.49) LARS1
SCHEMBL14999926 0.81 SLC16A3 (0.49) LARS1ALDH1A1OPRK1MAPTALOX5
SCHEMBL15000040 0.81 ALDH1A1 (0.49) GAAALDH1A1LMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461209-B2 Malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-06-11 US disclosed